Pharmarise Holdings (TSE:2796) Construction In Progress: 円169 Mil (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2796 Pharmarise Holdings Corp TSE:2796
50 GF Score
Price 円491.00
GF Value 円608.01
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Pharmarise Holdings Construction In Progress?

Pharmarise Holdings TSE:2796 -0.61% 50 Construction In Progress is 円169 Mil as of May. 2026. GuruFocus rates TSE:2796 with a GF Score™ of 50/100 and a GF Value™ of 円608.01 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Pharmarise Holdings's quarterly construction in progress declined from May. 2025 (円111 Mil) to Nov. 2025 (円0 Mil) but then increased from Nov. 2025 (円0 Mil) to May. 2026 (円169 Mil).

Pharmarise Holdings's annual construction in progress increased from May. 2024 (円14 Mil) to May. 2025 (円111 Mil) and increased from May. 2025 (円111 Mil) to May. 2026 (円169 Mil).

Pharmarise Holdings Construction In Progress Historical Data

* Premium members only.

The historical data trend for Pharmarise Holdings's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmarise Holdings Construction In Progress Chart

Pharmarise Holdings Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 115.00 30.00 14.00 111.00 169.00

Pharmarise Holdings Semi-Annual Data
Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25 May26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.00 0.00 111.00 0.00 169.00
TSE:2796
50GF Score
Pharmarise Holdings Corp TSE:2796
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmarise Holdings Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of 円169 Mil mean?
Pharmarise Holdings (TSE:2796) has a Construction In Progress of 円169 Mil as of May. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Pharmarise Holdings and its competitors.
Is Pharmarise Holdings' Construction In Progress too high?
Pharmarise Holdings' current Construction In Progress is 円169 Mil. Overall, Pharmarise Holdings has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharmarise Holdings' Construction In Progress compare to competitors?
Pharmarise Holdings' Construction In Progress of 円169 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Healthcare Providers & Services company?
A good Construction In Progress depends on the Healthcare Providers & Services industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Pharmarise Holdings and its competitors. Pharmarise Holdings's current Construction In Progress is 円169 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmarise Holdings stock overvalued right now?
Based on GuruFocus' analysis, Pharmarise Holdings (TSE:2796) is currently considered Modestly Undervalued. The stock's GF Value™ is 円608.01, compared to a current price of 円491.00 — trading 19.2% below its estimated fair value. The current Construction In Progress is 円169 Mil. Pharmarise Holdings' overall GF Score™ is 50/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Pharmarise Holdings (TSE:2796), the current Construction In Progress is 円169 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmarise Holdings (TSE:2796) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmarise Holdings stock appears to be undervalued. The current stock price of 円491.00 is trading 19.2% below its estimated GF Value™ of 円608.01. GuruFocus considers Pharmarise Holdings to be Modestly Undervalued.

Key valuation signals for TSE:2796:

  • Construction In Progress: 円169 Mil
  • GF Value™: 円608.01 vs. price of 円491.00 (19.2% below fair value)
  • GF Score™: 50/100 with 10 warning signs

No single metric tells the full story. See the TSE:2796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmarise Holdings Business Description

Address 8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on the prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.
50GF Score

Get the complete analysis for TSE:2796

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円491.00
Price
円608.01
GF Value